PDGFBB promotes PDGFRα-positive cell migration into artificial bone in vivo

Biochem Biophys Res Commun. 2012 May 18;421(4):785-9. doi: 10.1016/j.bbrc.2012.04.084. Epub 2012 Apr 23.

Abstract

Bone defects caused by traumatic bone loss or tumor dissection are now treated with auto- or allo-bone graft, and also occasionally by artificial bone transplantation, particularly in the case of large bone defects. However, artificial bones often exhibit poor affinity to host bones followed by bony union failure. Thus therapies combining artificial bones with growth factors have been sought. Here we report that platelet derived growth factor bb (PDGFBB) promotes a significant increase in migration of PDGF receptor α (PDGFRα)-positive mesenchymal stem cells/pre-osteoblastic cells into artificial bone in vivo. Growth factors such as transforming growth factor beta (TGFβ) and hepatocyte growth factor (HGF) reportedly inhibit osteoblast differentiation; however, PDGFBB did not exhibit such inhibitory effects and in fact stimulated osteoblast differentiation in vitro, suggesting that combining artificial bones with PDGFBB treatment could promote host cell migration into artificial bones without inhibiting osteoblastogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Becaplermin
  • Bone and Bones / cytology*
  • Cell Movement / drug effects*
  • Cell Movement / physiology
  • Cell Proliferation / drug effects
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Humans
  • Mesenchymal Stem Cells / drug effects*
  • Mesenchymal Stem Cells / metabolism
  • Mesenchymal Stem Cells / physiology
  • Mice
  • Osteoblasts / cytology
  • Osteoblasts / enzymology
  • Proto-Oncogene Proteins c-sis / pharmacology*
  • Receptor, Platelet-Derived Growth Factor alpha / metabolism*

Substances

  • Proto-Oncogene Proteins c-sis
  • Becaplermin
  • Receptor, Platelet-Derived Growth Factor alpha
  • Extracellular Signal-Regulated MAP Kinases